MLK-ELORALINTIDE
Eloralintide (also known as LY3841136) is an experimental, next-generation weight loss peptide being developed by Eli Lilly.
Unlike popular drugs like Wegovy or Zepbound which target gut hormones (GLP-1), eloralintide mimics a pancreatic hormone called amylin.
In Plain Words: What Is It?
Think of eloralintide as an appetite control switch. When you eat, your pancreas naturally releases amylin to signal to your brain that you are full. Eloralintide acts just like a super-charged, long-lasting version of that natural hormone to keep you feeling full longer and curb food cravings.
Key Benefits
Clinical data reveals powerful weight management advantages:
Significant Weight Loss: In clinical trials, people taking the highest dose lost up to 20% of their total body weight over 48 weeks.
Targeted Fat Loss: Body scans show that the weight lost is almost entirely pure fat mass, rather than muscle tissue.
Better Tolerability: Because it selectively targets specific brain receptors, it appears to cause much less severe nausea, diarrhea, and vomiting than current GLP-1 weight-loss medications.
Is it Systemic and How Does It Work?
Yes, eloralintide is completely systemic.
How it is taken: It is designed as a once-weekly injection underneath the skin (subcutaneous).
How it moves: Once injected, it enters the bloodstream and travels throughout the entire body to reach the brainstem.
What it does inside: In the brain, it triggers receptors that slow down how fast your stomach empties food and sends powerful "satiety" signals, effectively turning down your appetite.
What is its Half-Life?
Eloralintide has a remarkably long half-life of about 2 weeks.
Why this matters: Natural amylin breaks down in the body in just a matter of minutes.
The structural engineering: Scientists modified the peptide chain so that it clears out of the system very slowly. This 2-week half-life ensures the drug levels stay completely steady in your blood, allowing for a convenient once-a-week dose.
Current Status
It is not approved by the FDA yet. After successful Phase 2 results, large-scale Phase 3 clinical trials are underway to fully prove its safety and effectiveness before it can be prescribed by doctors.
Would you like to look at the most common side effects found in the trials, or see how scientists are testing it in combination with other drugs like tirzepatide (Zepbound)?
Current Status
Not a Drug Yet: You cannot buy this at a store or get it from a doctor.
Lab Testing Only: It is still being tested in labs on cells and animals to make sure it is safe.
For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.
⚠️Important Notice:
This product is intended for in-vitro laboratory research use only. It is not for human or veterinary use. Molekula USA does not condone the ingestion or injection of this compound. All customers must be qualified researchers.
Current Status
Not a Drug Yet: You cannot buy this at a store or get it from a doctor.
Lab Testing Only: It is still being tested in labs on cells and animals to make sure it is safe.
For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.
⚠️Important Notice:
This product is intended for in-vitro laboratory research use only. It is not for human or veterinary use. Molekula USA does not condone the ingestion or injection of this compound. All customers must be qualified researchers.
Your Inquiry Matters
Have a question about our research-only compounds or quality standards?
Reach out using the form below. Our team responds with compliant guidance for laboratory and analytical inquiries.